Apotex Announces First Quarter 2027 Results
PR Newswire•12/08/2026•05:59 ET
0
Whiz Insights
– Launch Momentum Supports FY 2027 Guidance: Upper Mid-Single Digit Revenue Growth and ~ 30% Adjusted EBITDA Margin
– Successfully Completed Upsized IPO and Applied $800 Million of Proceeds to Debt Repayment
Get started
Create a free account to read the full story.